Topeline data were announced from a phase 3 trial evaluating SB-01 for intradiscal treatment of patients with CLBP associated with DDD.

Large postpandemic prevalence increases were seen in functional dyspepsia and irritable bowel syndrome. HealthDay News — The prevalence of disorders of the gut-brain interaction (DGBI) increased from ...

While most cases of bug bites can be managed at home, some symptoms are more serious and should prompt patients to seek ...

HealthDay News — Each year, nearly 74,000 children are born with hepatitis C virus (HCV) around the world, according to a study published online July 23 in The Lancet Gastroenterology and Hepatology.

Your patient with gout is undergoing evaluation prior to initiation of urate-lowering therapy (ULT). According to the American College of Rheumatology (ACR) guidelines, anti-inflammatory prophylaxis ...

HealthDay News — The U.S. Preventive Services Task Force (USPSTF) recommends screening adults for unhealthy alcohol use and providing brief behavioral counseling interventions for those engaged in ...

The FDA is allowing Sarepta to resume shipments of Elevidys (delandistrogene moxeparvovec) to ambulatory patients with Duchenne muscular dystrophy.

Access to green spaces before, during and after pregnancy may lower the risk for neurodevelopmental disorders in children.

GLP-1 RA use increases risk for nonarteritic anterior ischemic optic neuropathy compared with other second-line antidiabetic medications.

Long COVID risk was linked to financial hardship, food insecurity, less than a college education, and lack of social support.

The FDA hopes education and legal action against 7-OH products will help prevent a second opioid crisis in the US.

The FDA has extended the review period for elinzanetant for the treatment of moderate to severe vasomotor symptoms due to menopause.